Tag

HIV Research

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More

HIV Vaccines Could Vastly Improve HIV Prevention – And You Can Help

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
There were a reported 2.1 million new HIV infections in 2015, and 36.7 million people are currently living with HIV/AIDS globally. Vaccines could be an incredibly powerful tool in the fight against HIV/AIDS, with the potential to dramatically reduce the number of new HIV infections around the world. In continuation of Fenway Health’s decades-long commitment to treating and preventing HIV/AIDS, The Fenway Institute is excited to serve as a study site for several HIV vaccine trials, including HVTN 108. HVTN 108 will examine both tolerability of a new HIV vaccine and the immune system’s response to it. It’s important to 
Read More

Help Shape The Future Of HIV Prevention: Join A Research Study Today

By | HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
The battle against HIV/AIDS has shifted dramatically in the past decade, as our understanding of the virus and how to combat it has increased. The introduction of Pre-Exposure Prophylaxis (PrEP), a daily pill commonly known as Truvada, has been an incredible game changer for HIV prevention. Currently, condom use and PrEP are the most proven effective methods for protection against HIV infection. “Using Truvada for PrEP has been revolutionary for HIV prevention, but, unfortunately, it’s not a one size fits all solution,” said Ryan Tappin, Clinical Manager, Biomedical Research at The Fenway Institute. “The more choices for PrEP that patients 
Read More

The Fenway Institute Helps Develop Model Of HIV Care For Transgender Women In Peru

By | HIV/AIDS, Research, The Fenway Institute, Trans, Women's Health | No Comments
More than 100 transgender women in Lima, Peru, have joined an amfAR-funded study that aims to determine if combining HIV prevention and treatment with gender-affirming medical care will help these women access health services and remain in care. Transgender women have the highest prevalence of HIV in Peru—30 percent in Lima, according to one study, yet the least access to services. “Stigma and discrimination are powerful barriers that prevent transgender women from participating in society,” said principal investigator Dr. Javier Lama of Asociación Civil Impacta Salud y Educación (IMPACTA), a nonprofit that conducts HIV/AIDS research. “The staff of most public 
Read More

Study Explores New HIV Linkage to Care Model

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
According to the U.S. Centers for Disease Control and Prevention, MSM continue to be the group most heavily affected by HIV in the US; while they represent only two percent of the U.S. population, MSM account for nearly 67% of newly diagnosed HIV infections. That burden is even heavier for gay and bisexual African American men. The CDC reports that from 2005 to 2014, the number of new HIV diagnoses among young African American gay and bisexual men increased 87%. These troubling numbers highlight the need for a variety linkage to care models to ensure that these men regularly take 
Read More